Benign neoplasm of male genital organs
Chapter 2:Neoplasms
ICD-10 D29 is a billable code used to indicate a diagnosis of benign neoplasm of male genital organs.
Benign neoplasms of the male genital organs encompass a variety of non-cancerous tumors that can occur in structures such as the prostate, testicles, and penis. These neoplasms may present as palpable masses or be discovered incidentally during imaging or surgical procedures. Common types include benign prostatic hyperplasia (BPH), testicular tumors (such as Leydig cell tumors), and penile lesions (such as penile fibromas). Symptoms may vary depending on the location and size of the neoplasm, with BPH often leading to urinary symptoms such as frequency, urgency, and difficulty urinating. Diagnosis typically involves imaging studies, such as ultrasound or MRI, and may require biopsy for definitive characterization. Management strategies can range from watchful waiting to surgical intervention, depending on the symptoms and the specific type of neoplasm. Regular follow-up is essential to monitor for any changes in size or symptoms, ensuring timely intervention if necessary.
Detailed descriptions of the neoplasm, including size, location, and any associated symptoms.
Evaluation of patients with urinary symptoms, incidental findings on imaging, or palpable masses.
Ensure accurate coding based on biopsy results and imaging findings.
Comprehensive reports on tumor characteristics and treatment plans.
Management of patients with benign tumors that may require surgical intervention.
Differentiation from malignant tumors is crucial for accurate coding.
Used for symptomatic BPH management.
Document indications for surgery and pre-operative evaluations.
Urology specialists should ensure accurate coding based on the procedure performed.
Benign neoplasms are non-cancerous growths that do not invade surrounding tissues or metastasize, while malignant neoplasms are cancerous and can spread to other parts of the body.
